• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

08/07/2025 09:50

Nectar Lifesciences posts Q4 net loss of Rs 130.09 cr

The company reported standalone net loss during the quarter stood at Rs 130.09 crore compared to net profit of Rs 0.60 crore in the previous year quarter.ÿ

Net revenue of the company declined marginally by 2.49 per cent at Rs 428.91 crore in January-March quarter of this fiscal as against Rs 439.85 crore in the corresponding period last year.

During January-March quarter, operating expenses increased by 48.91 per cent to Rs 585.00 crore from Rs 392.86 crore in year ago period.

Other Income dipped by 94.56 per cent at Rs 0.08 crore versus (Mar'24 Rs 1.47 crore).

Operating Profit slipped by 418.08 per cent to Rs -154.30 crore as against Rs 48.51 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 426.20 per cent in March quarter.

Interest declined by 26.86 per cent y-o-y to Rs 17.67 crore, while Taxation decreased by 647.34 per cent at Rs -57.58 crore (Mar'24 Rs 10.52 crore).